Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Calvet

Showing results (11-20 of 230) with videos related to

Pageof 23
Sort By:
Drugs|December 13, 2005
What is potent acid inhibition, and how can it be achieved?Xavier Calvet, Fernando Gomollón
Gastroenterologia Y Hepatologia|September 29, 2012
[Esophageal diseases: gastroesophageal reflux disease and Barrett's esophagus]Xavier Calvet, Albert Villoria
Gastroenterologia Y Hepatologia|October 29, 2013
[Esophageal diseases: gastroesophageal reflux disease, Barrett's esophagus, achalasia and eosinophilic esophagitis]Xavier Calvet, Albert Villoria
Drugs|December 13, 2005
Optimising acid inhibition treatmentFernando Gomollón, Xavier Calvet
Gastroenterologia Y Hepatologia|May 13, 2009
[Gastroesophageal reflux disease: epidemiology, diagnosis and treatment]Xavier Calvet, Julio Ponce
Revista Espanola De Enfermedades Digestivas|March 28, 2023
Relevance of patient-reported outcome measures (PROM) and patient-reported experience measures (PREM) to assess disease status and quality of care in patients with inflammatory bowel diseaseYamile Zabana, Xavier Calvet
Reumatologia Clinica|July 22, 2014
How to compare biologic drugsXavier Calvet, Juan Vicente Esplugues,
Healthcare (Basel, Switzerland)|September 28, 2023
Prevalence and Characteristics of Sexual Victimization among Gay and Bisexual Men: A Preliminary Study in SpainXavier Calvet, Leonor M Cantera
Clinical and Translational Gastroenterology|March 29, 2013
Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive ReviewJavier P Gisbert, Xavier Calvet
Clinical and Experimental Gastroenterology|March 30, 2012
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pyloriJavier P Gisbert, Xavier Calvet
Pageof 23

Showing results (11-20 of 230) with videos related to

Sort By:
Pageof 23
Drugs|December 13, 2005
What is potent acid inhibition, and how can it be achieved?Xavier Calvet, Fernando Gomollón
Gastroenterologia Y Hepatologia|September 29, 2012
[Esophageal diseases: gastroesophageal reflux disease and Barrett's esophagus]Xavier Calvet, Albert Villoria
Gastroenterologia Y Hepatologia|October 29, 2013
[Esophageal diseases: gastroesophageal reflux disease, Barrett's esophagus, achalasia and eosinophilic esophagitis]Xavier Calvet, Albert Villoria
Drugs|December 13, 2005
Optimising acid inhibition treatmentFernando Gomollón, Xavier Calvet
Gastroenterologia Y Hepatologia|May 13, 2009
[Gastroesophageal reflux disease: epidemiology, diagnosis and treatment]Xavier Calvet, Julio Ponce
Revista Espanola De Enfermedades Digestivas|March 28, 2023
Relevance of patient-reported outcome measures (PROM) and patient-reported experience measures (PREM) to assess disease status and quality of care in patients with inflammatory bowel diseaseYamile Zabana, Xavier Calvet
Reumatologia Clinica|July 22, 2014
How to compare biologic drugsXavier Calvet, Juan Vicente Esplugues,
Healthcare (Basel, Switzerland)|September 28, 2023
Prevalence and Characteristics of Sexual Victimization among Gay and Bisexual Men: A Preliminary Study in SpainXavier Calvet, Leonor M Cantera
Clinical and Translational Gastroenterology|March 29, 2013
Helicobacter Pylori "Test-and-Treat" Strategy for Management of Dyspepsia: A Comprehensive ReviewJavier P Gisbert, Xavier Calvet
Clinical and Experimental Gastroenterology|March 30, 2012
Update on non-bismuth quadruple (concomitant) therapy for eradication of Helicobacter pyloriJavier P Gisbert, Xavier Calvet
Pageof 23